Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-045468
Filing Date
2020-12-30
Accepted
2020-12-30 17:00:15
Documents
1
Group Members
MARLENE KRAUSS, M.D.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ea132419-13da2krauss_180life.htm SC 13D/A 93575
  Complete submission text file 0001213900-20-045468.txt   95164
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Subject) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90013 | Film No.: 201426489
SIC: 2834 Pharmaceutical Preparations

Mailing Address 527 STANTON CHRISTIANA ROAD NEWARK DE 19713
Business Address 527 STANTON CHRISTIANA ROAD NEWARK DE 19713 3025022727
KBL IV SPONSOR LLC (Filed by) CIK: 0001706868 (see all company filings)

EIN.: 821511410 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A